ArticlePharmacoEconomics - open2023

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis.

Julie Vanderpoel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.